Selected-GenAtlas references SOURCE GeneCards NCBI Gene Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol MUC3A contributors: mct - updated : 23-10-2010
HGNC name mucin 3A, cell surface associated
HGNC id 7513
EXPRESSION
Type restricted
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveintestinesmall intestine   
Urinarykidney    
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period embryo
Text weakly in immature tubule
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • N terminal repetitive structures, one with an array of 20 short tandemly repeated structures, the second encoding a major serine/threonine domain
  • an extracellular cysteine-rich domain with 2 epidermal growth factor (EGF)-like motifs
  • a C terminal non repetitive mucin-like, a SEA (sea urchin sperm protein, enterokinase and agrin) module, with an intrinsic proteolytic site sequence G downward arrow SIVV (where G downward arrow S is the glycine serine cleavage site)
  • conjugated GlycoP
    HOMOLOGY
    Homologene
    FAMILY
    CATEGORY secretory , signaling
    SUBCELLULAR LOCALIZATION extracellular
        plasma membrane
    basic FUNCTION
  • involved in epithelial cell protection
  • adhesion modulation and signaling
  • membrane-bound glycoprotein that is aberrantly expressed in carcinomas
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
    cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --other  
    aberrantly expressed in several carcinomas
    Susceptibility Crohn's disease and ulcerative colitis
    Variant & Polymorphism
    Candidate gene
    Marker
  • methylation status of the MUC3A promoter may be a novel epigenetic marker for the diagnosis of carcinogenic risk and prediction of outcomes for cancer patients
  • Therapy target represents a potential novel therapeutic agent for intestinal wound healing
    ANIMAL & CELL MODELS